Equities

Suzhou MedicalSystem Technology Co Ltd

603990:SHH

Suzhou MedicalSystem Technology Co Ltd

Actions
Health CareHealth Care Providers
  • Price (CNY)8.27
  • Today's Change-0.17 / -2.01%
  • Shares traded13.77m
  • 1 Year change-38.28%
  • Beta0.8980
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Suzhou MedicalSystem Technology Co Ltd had net income fall from a gain of 33.56m to a loss of 269.42m despite a 102.33% increase in revenues from 305.51m to 618.14m. An increase in the cost of goods sold as a percentage of sales from 29.48% to 80.88% was a component in the falling net income despite rising revenues.
Gross margin4.75%
Net profit margin-39.43%
Operating margin-39.60%
Return on assets-8.41%
Return on equity-24.86%
Return on investment-15.81%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Suzhou MedicalSystem Technology Co Ltd fell by 469.03m. Cash Flow from Financing totalled 710.16m or 114.89% of revenues. In addition the company used 316.65m for operations while cash used for investing totalled 862.53m.
Cash flow per share--
Price/Cash flow per share--
Book value per share3.33
Tangible book value per share2.90
More ▼

Balance sheet in CNYView more

Suzhou MedicalSystem Technology Co Ltd has a Debt to Total Capital ratio of 60.87%, a higher figure than the previous year's 21.64%.
Current ratio0.5475
Quick ratio0.5109
Total debt/total equity1.56
Total debt/total capital0.6087
More ▼

Growth rates in CNY

Year on year, growth in earnings per share excluding extraordinary items dropped -814.98%.
Div yield(5 year avg)0.11%
Div growth rate (5 year)--
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-591.07
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.